MedTrace Logo

Prevalence and Pathophysiology of Sarcopenia in the Elderly Patient With Hip Fracture

NCT01477086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 198

Last updated 2016-02-05

No results posted yet for this study

Summary

Sarcopenia is the loss of muscle mass and function that accompanies aging. The term sarcopenia comes from the Greek "sarx" (flesh) and "penia" (loss).

Sarcopenia is a topic of great interest to geriatricians, and from 2010 discussing the possibility of considering it as a geriatric syndrome.

Diagnostic criteria are reduced muscle mass, reduced strength and impaired physical performance. The presence of muscle mass reduction set presarcopenia diagnosis, when combined with one of the other two are talking about sarcopenia and when are the three is defined as severe sarcopenia.

The hypothesis of our study is that sarcopenia is highly prevalent in older people with hip fracture. The increase in inflammatory indices of older people, along with bed rest, represent factors that accelerate the development of sarcopenia. These factors together could be the base of the high percentage of patients who do not recover the degree of autonomy before the fracture.

Conditions

Sponsors & Collaborators

  • University of Navarra

    collaborator OTHER

  • Hospital Viamed Valvanera, Spain

    lead OTHER

Principal Investigators

  • Vincenzo Malafarina, MD MSc · Clinica Los Manzanos, Lardero, Spain

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01477086 on ClinicalTrials.gov